These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 28919468)
1. A copper based enzyme-free fluorescence ELISA for HER2 detection. Tian S; Zeng K; Yang A; Wang Q; Yang M J Immunol Methods; 2017 Dec; 451():78-82. PubMed ID: 28919468 [TBL] [Abstract][Full Text] [Related]
2. A sandwich-type electrochemical immunosensor based on in situ silver deposition for determination of serum level of HER2 in breast cancer patients. Shamsipur M; Emami M; Farzin L; Saber R Biosens Bioelectron; 2018 Apr; 103():54-61. PubMed ID: 29278813 [TBL] [Abstract][Full Text] [Related]
3. A Multicolor Immunosensor for Sensitive Visual Detection of Breast Cancer Biomarker Based on Sensitive NADH-Ascorbic-Acid-Mediated Growth of Gold Nanobipyramids. Wang Z; Chen Q; Zhong Y; Yu X; Wu Y; Fu F Anal Chem; 2020 Jan; 92(1):1534-1540. PubMed ID: 31790576 [TBL] [Abstract][Full Text] [Related]
4. pH-responsive allochroic nanoparticles for the multicolor detection of breast cancer biomarkers. Xu W; Jiao L; Ye H; Guo Z; Wu Y; Yan H; Gu W; Du D; Lin Y; Zhu C Biosens Bioelectron; 2020 Jan; 148():111780. PubMed ID: 31665670 [TBL] [Abstract][Full Text] [Related]
5. Photoelectrochemical detection of breast cancer biomarker based on hexagonal carbon nitride tubes. Luo J; Liang D; Qiu X; Yang M Anal Bioanal Chem; 2019 Oct; 411(26):6889-6897. PubMed ID: 31401668 [TBL] [Abstract][Full Text] [Related]
6. Sensitive determination of the human epidermal growth factor receptor 2 (HER2) by immuno-polymerase chain reaction with inductively coupled plasma-mass spectrometry detection. Asensio AF; Sierra LM; Montes-Bayón M; Blanco-González E Anal Chim Acta; 2019 Dec; 1090():39-46. PubMed ID: 31655644 [TBL] [Abstract][Full Text] [Related]
7. Serum HER2 level measured by dot blot: a valid and inexpensive assay for monitoring breast cancer progression. Tan LD; Xu YY; Yu Y; Li XQ; Chen Y; Feng YM PLoS One; 2011 Apr; 6(4):e18764. PubMed ID: 21533253 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of a manual ELISA kit for determination of HER2/neu in serum of breast cancer patients. Gauchez AS; Ravanel N; Villemain D; Brand FX; Pasquier D; Payan R; Mousseau M Anticancer Res; 2008; 28(5B):3067-73. PubMed ID: 19031958 [TBL] [Abstract][Full Text] [Related]
9. Immunoelectrochemical detection of the human epidermal growth factor receptor 2 (HER2) via gold nanoparticle-based rolling circle amplification. Shen C; Liu S; Li X; Zhao D; Yang M Mikrochim Acta; 2018 Nov; 185(12):547. PubMed ID: 30426312 [TBL] [Abstract][Full Text] [Related]
10. Enzyme-free detection of sequence-specific microRNAs based on nanoparticle-assisted signal amplification strategy. Li RD; Wang Q; Yin BC; Ye BC Biosens Bioelectron; 2016 Mar; 77():995-1000. PubMed ID: 26547010 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in nanomaterials-based electrochemical immunosensors and aptasensors for HER2 assessment in breast cancer. Ahirwar R Mikrochim Acta; 2021 Sep; 188(10):317. PubMed ID: 34476602 [TBL] [Abstract][Full Text] [Related]
12. Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients. Banys-Paluchowski M; Witzel I; Riethdorf S; Rack B; Janni W; Fasching PA; Solomayer EF; Aktas B; Kasimir-Bauer S; Pantel K; Fehm T; Müller V Anticancer Res; 2017 Jun; 37(6):3117-3128. PubMed ID: 28551653 [TBL] [Abstract][Full Text] [Related]
13. Biomarker triplet NAMPT/VEGF/HER2 as a de novo detection panel for the diagnosis and prognosis of human breast cancer. Zhu Y; Guo M; Zhang L; Xu T; Wang L; Xu G Oncol Rep; 2016 Jan; 35(1):454-62. PubMed ID: 26531769 [TBL] [Abstract][Full Text] [Related]
14. Dual signal amplification photoelectrochemical biosensor for highly sensitive human epidermal growth factor receptor-2 detection. Guo X; Liu S; Yang M; Du H; Qu F Biosens Bioelectron; 2019 Aug; 139():111312. PubMed ID: 31136922 [TBL] [Abstract][Full Text] [Related]
15. Three-dimensional porous calcium alginate fluorescence bead-based immunoassay for highly sensitive early diagnosis of breast cancer. Chia YY; Theverajah TM; Alias Y; Khor SM Anal Bioanal Chem; 2022 Jan; 414(3):1359-1373. PubMed ID: 34839383 [TBL] [Abstract][Full Text] [Related]
16. A novel antibody-antigen based impedimetric immunosensor for low level detection of HER2 in serum samples of breast cancer patients via modification of a gold nanoparticles decorated multiwall carbon nanotube-ionic liquid electrode. Arkan E; Saber R; Karimi Z; Shamsipur M Anal Chim Acta; 2015 May; 874():66-74. PubMed ID: 25910448 [TBL] [Abstract][Full Text] [Related]
17. Development of screen-printed electrode based immunosensor for the detection of HER2 antigen in human serum samples. Tallapragada SD; Layek K; Mukherjee R; Mistry KK; Ghosh M Bioelectrochemistry; 2017 Dec; 118():25-30. PubMed ID: 28692846 [TBL] [Abstract][Full Text] [Related]
18. Electrochemical immunosensor for the analysis of the breast cancer biomarker HER2 ECD. Marques RC; Viswanathan S; Nouws HP; Delerue-Matos C; González-García MB Talanta; 2014 Nov; 129():594-9. PubMed ID: 25127638 [TBL] [Abstract][Full Text] [Related]
19. Sensitive sandwich ELISA based on a gold nanoparticle layer for cancer detection. Zhou F; Wang M; Yuan L; Cheng Z; Wu Z; Chen H Analyst; 2012 Apr; 137(8):1779-84. PubMed ID: 22278156 [TBL] [Abstract][Full Text] [Related]
20. Serum HER-2/neu: a new predictive marker. Voss A; Neumann R Int J Clin Pharmacol Ther; 2002 Dec; 40(12):584-5. PubMed ID: 12503824 [No Abstract] [Full Text] [Related] [Next] [New Search]